Merge Healthcare Incorporated (NASDAQ: MRGE), a leading provider of clinical systems and innovations that seek to transform healthcare, today announced that The Valley Hospital selected Merge’s CTMS for Investigators solution to organize and centralize enterprise-wide clinical research operations.
“We needed a system that would allow us to centralize capture of study data for a large volume of studies,” said Sonia Kleiner-Arje, Director of Research Administration, Research Department at The Valley Hospital. “Our team specializes in oncology and cardiology studies, but the hospital is expanding to include studies across all therapeutic areas. As we evaluated the options, we selected Merge CTMS for Investigators because of the flexibility it offered to track all study types and the overall ease-of-use.”
“The system’s comprehensive budgeting features provide us with the insight needed to better negotiate with study sponsors before we decide whether to take on a study,” continued Kleiner-Arje. “Also important was the system’s flexible reporting options which allow us to quickly and easily report results to key stakeholders. We believe Merge CTMS will provide us with substantial business insight for our clinical research operations.”
“We are pleased that The Valley Hospital has selected Merge CTMS as a solution for their clinical research business and operational needs,” said Zaher El-Assi, President, eClinical at Merge. “Merge CTMS for Investigators delivers powerful results for any size research operation, and consolidates study information in one place. By implementing an enterprise-wide CTMS, The Valley Hospital is primed to streamline data collection and reporting, take control of study finances, improve the bottom line, and drive long-term site success.”
Through enhanced productivity and business management tools, Merge CTMS for Investigators allows research organizations to centralize study information, organize research activities, and improve recruitment and financial performance. Merge CTMS scales easily from one to many sites, offering a comprehensive suite of CTMS tools for independent research sites, physician networks, SMOs, hospitals, health systems and academic medical centers.
About Merge Healthcare
Merge is a leading provider of clinical systems and innovations that seek to transform healthcare. Merge’s enterprise and cloud-based solutions for image intensive specialties provide access to any image, anywhere, any time. Merge also provides health stations, clinical trials software and other health data and analytics solutions that engage consumers in their personal health. With solutions that are used by providers and consumers and include more than 20 years of innovation, Merge is helping to reduce costs and improve the quality of healthcare worldwide. For more information, visit merge.com.
About The Valley Hospital
The Valley Hospital is a fully accredited, acute care, not-for-profit hospital serving more than 440,000 people in 32 towns in Bergen County and adjoining communities. Valley is a leader in the field of cardiology services, including a full range of diagnostic and interventional cardiac treatment services, including cardiac surgery, coronary angioplasty and electrophysiology studies. Valley is also widely known for its excellence in lung cancer diagnosis and treatment, radiation oncology (including tomotherapy), chemotherapy and infusion, GYN oncology, prostate cancer care, and other clinical and support services. For more information, visit valleyhealth.com.
Cautionary Notice Regarding Forward-Looking Statements
The matters discussed in this news release may include forward-looking statements, which could involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, such forward-looking statements. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements.